Human centrosomal epitope is shared specifically with human lactate dehydrogenase-B isozyme

F Gosti1, S S Li, R Maunoury

  • 1Centre de Génétique Moléculaire, CNRS, Gif-sur-Yvette, France.

FEBS Letters
|March 16, 1992
PubMed

Insights

Rabbit serum 0013 identifies a specific epitope on human lactate dehydrogenase B (LDH-B) subunits. This finding provides the most potent anti-LDH-B serum available for research.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Immunology

Background:

  • Rabbit serum 0013 was initially used to identify centrosomal proteins.
  • The serum also recognized a 36 kDa non-centrosomal protein, identified as human lactate dehydrogenase (LDH).
  • The co-distribution of the 0013 epitope on centrosomal proteins and LDH was found to be specific to human cells, with human hepatic cells being an exception.

Purpose of the Study:

  • To investigate the specificity of the 0013 epitope in human cells.
  • To determine the precise target of the 0013 epitope within lactate dehydrogenase.
  • To characterize the anti-LDH-B activity of serum 0013.

Main Methods:

  • Immunological assays using rabbit serum 0013.
  • Analysis of human hepatic cells expressing only the LDH-A4 isozyme.
  • Characterization of lactate dehydrogenase subunits.

Main Results:

  • The 0013 epitope is specific for the human LDH-B subunit.
  • Serum 0013 demonstrates high specificity for LDH-B.
  • Human hepatic cells, expressing only LDH-A4, confirmed the epitope's specificity for LDH-B.

Conclusions:

  • Serum 0013 is a highly specific reagent for detecting the human LDH-B subunit.
  • This specificity offers a valuable tool for studying LDH-B in various biological contexts.
  • The findings prompt further investigation into the evolutionary and physiological significance of LDH-B specificity.

Related Concept Videos